Trial intelligence / Profile preview

Platelet Reactivity After TAVI

2014-003599-21Phase 4Completed

Sponsor
Sociedad Española de Cardiología
Start
Apr 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in aortic stenosis (AS) comparing Ticagrelor monotherapy with Aspirin plus clopidogrel (2 arms). Primary endpoint: Residual platelet reactivity at 3 months. Started Apr 2015; status: completed.

02

Drugs

ticagrelorclopidogrelaspirin
03

Conditions

aortic stenosis (AS)

Beyond the preview

Go deeper on 2014-003599-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003599-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call